PharmaCyte Biotech, Inc. (Nasdaq: PMCB), an SEC filer in Biological Products, (No Diagnostic Substances), closed at $0.52, -4.7%, on 2026-08-28, with a market cap of $6M as of 2026-08-27, a trailing P/E of 0.2 and a return on equity of 77.1%. Institutional ownership, earnings history and filed financials are on the tabs below.
| # | Holder | Shares | Value | % of shares out | Δ QoQ |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 359,547359,547 | $239,243 | 3.35% | ADD 57% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 195,660195,660 | $130,200 | 1.82% | ADD 58% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 56,50056,500 | $37,595 | 0.53% | TRIM -40% |
| 4 | XTX Topco Ltd | 52,36252,362 | $34,842 | 0.49% | ADD 114% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 51,46751,467 | $34,226 | 0.48% | NEW |
| 6 | Virtu Financial LLC | 37,53237,532 | $25,000 | 0.35% | NEW |
| 7 | NORTHERN TRUST CORP | 35,60135,601 | $23,689 | 0.33% | — |
| 8 | Schonfeld Strategic Advisors LLC | 27,00927,009 | $17,971 | 0.25% | ADD 3% |
| 9 | HRT FINANCIAL LP | 24,74124,741 | $16,000 | 0.23% | TRIM -86% |
| 10 | VANGUARD FIDUCIARY TRUST CO | 23,45223,452 | $15,596 | 0.22% | NEW |
Ranked by each filer’s own reported value, not shares.
2 holders — The filer reported no value for this line, so it carries no dollar figure and is left out of the percentage and value columns.
| Biggest buyers | Δ shares | Δ value | |
|---|---|---|---|
| CITADEL ADVISORS LLC | +129,825 | $86,386 | ADD |
| GEODE CAPITAL MANAGEMENT, LLC | +71,816 | $47,786 | ADD |
| VANGUARD CAPITAL MANAGEMENT LLC | +51,467 | $34,246 | OPEN |
| Virtu Financial LLC | +37,532 | $24,974 | OPEN |
| XTX Topco Ltd | +27,920 | $18,578 | ADD |
| Biggest sellers | Δ shares | Δ value | |
|---|---|---|---|
| HRT FINANCIAL LP | −158,060 | $105,173 | TRIM |
| SABBY MANAGEMENT, LLC | −100,000 | $66,540 | CLOSE |
| VANGUARD GROUP INC | −74,919 | $49,851 | CLOSE |
| RENAISSANCE TECHNOLOGIES LLC | −37,536 | $24,976 | TRIM |
| TWO SIGMA SECURITIES, LLC | −8,193 | $5,452 | TRIM |
Prior quarter split-rebased · 13Fs are long, US-listed only.
| Holder | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | — | — | — | 15K | 230K | 360K | $239,243 |
| GEODE CAPITAL MANAGEMENT, LLC | 165K | 139K | 127K | 127K | 124K | 196K | $130,200 |
| RENAISSANCE TECHNOLOGIES LLC | 49K | 50K | 50K | 80K | 94K | 57K | $37,595 |
| XTX Topco Ltd | — | — | — | — | 24K | 52K | $34,842 |
| VANGUARD CAPITAL MANAGEMENT LLC | — | — | — | — | — | 51K | $34,226 |
| Virtu Financial LLC | — | — | — | — | — | 38K | $25,000 |
| NORTHERN TRUST CORP | 19K | 19K | 19K | 19K | 36K | 36K | $23,689 |
| Schonfeld Strategic Advisors LLC | 26K | 26K | 26K | 26K | 26K | 27K | $17,971 |
| HRT FINANCIAL LP | — | — | — | — | 183K | 25K | $16,000 |
| VANGUARD FIDUCIARY TRUST CO | — | — | — | — | — | 23K | $15,596 |
Green = added, red = trimmed, grey = held; a dash is a quarter with no 13F on file — a gap, not an exit.
Breaks = no 13F that quarter.
Short interest has its own tab now — open SI →
SEC Form 13F · ~10,250 filers, 10y · long-only, US-listed, filed ≤45d after quarter-end.
